Two humanized antibody mutants, hLL2HCNl and hLL2HCN5, engineered with CHj domain-appended carbohydrates (CHOs) were generated to facilitate site-specific conjugation of radionuclides and anti-cancer drugs to antibodies. Such site-specific conjugation may minimize the incidence of immunoreactivity perturbation as is often observed with random conjugation. Since the compositions and structures of CHOs are important in determining the chemistry, efficiency, and extent of conjugation, the sequences of the CH,-appended CHOs were determined by exoglycosidase digestions and fluorophore-assisted CHO electrophoresis (FACE). The CHO species attached at HCN1 and HCN5 sites in hLL2HCNl and hLL2HCN5, respectively, were distinct from each other, heterogeneous, and extensively processed. All of these CHOs were corefucosylated complex-type oligosaccharides and contained Gal (galactose) and GlcNAc (N-acetylglucosamine) residues in the outer branches. Some of the outer branches were composed of Galal-3Gaipi-4GlcNAc structure, also known as a-galactosyl epitope. Most of the CHOs were sialylated. While all HCNl-CHOs were biantennary, the majority of HCN5-CHOs (>60%) were triantennary. The CH x -appended CHOs have favorable structural characteristics suitable for site-specific conjugation. For efficient conjugation of large drug complexes, hLL2HCN5 is preferable to hLL2HCNl because the attached CHO is larger in size and more remotely positioned from the V region. The effects of the a-galactosyl epitope found in these CHOs on the inununological properties of the immunoconjugates as efficient cancer diagnostics and therapeutics are being studied.
Introduction
To develop monoclonal antibody (mAb) conjugates as targeting agents in cancer diagnosis and therapy, the availability of methods for site-specific conjugation is essential, because random conjugation often results in immunoconjugates with reduced antigen (Ag) binding properties. Carbohydrate (CHO) moieties on antibodies (Abs) have been demonstrated to be efficient and superior sites for site-specific attachment of radionuclides, drugs and peptides, because the chemistry for CHO-specific modification is well-defined (Meares et al, 1984; Rodwell et al, 1986; Shih et al, 1991; Leung et al., 1995b) .
Although all Abs are glycoproteins, most of the CHOs are N-linked glycans commonly found in the CH 2 domain at Asn297. Conjugation of the reagents of clinical interests to IgGs through the CH 2 -appended CHOs is only applicable to intact Abs, but not to Fc-depleted Ab fragments, such as F(ab') 2 , Fab', and Fab. Moreover, since the Asn297-associated CHOs are positioned at the internal space formed between the two adjacent CH 2 domains, steric hindrance is expected to render conjugation at these sites less efficient (Sutton and Phillips, 1983) .
Additional N-linked CHOs have been found in the variable (V) regions of approximately 25% of naturally occurring IgGs (Abel et al., 1968) . Since removal or modification of the V region-appended CHOs, especially those attached to the complementarity determining regions (CDRs) are likely to affect the immunoreactivity of the Abs, it is therefore undesirable to use these CHOs as the conjugation sites. Some N-linked CHOs located on the framework (FR) sequences in the V domains, however, are not directly involved in Ag binding and were proven superior as handles for the site-specific attachment of chelates. For example, when DTPA (diethylenetriaminepentaacetic acid) was site-specifically conjugated to the F(ab') 2 fragment of murine LL2, an anti-CD22 mAb (PawlakByczkowska et al., 1989; Stein et al., 1993) , through its VK FRl-appended CHOs, the resultant conjugates retained 100% of the immunoreactivity, whereas random conjugation of comparable number of DTPA resulted in 80% reduction in immunoreactivity (Leung et al, 1995b) . However, when larger molecules, such as the 18 kDa dextran-DOX complexes, were conjugated to the same CHOs, a significant reduction (-60%) in immunoreactivity of the Ab was observed, suggesting that the distance between the Vic-appended CHO to the Ag binding site (ABS) might still be too close (Qu et al., unpublished observations) .
We have designed and engineered a battery of glycosylation mutants of humanized LL2 (hLL2) (Leung et al., 1995a) in order to generate novel conjugation sites with improved characteristics. The glycosylation sites, HCN1 and HCN5, that were introduced into the CH, domains of two mutants, hLL2HCNl and hLL2HCN5, respectively, exhibited favorable accessibilities for glycosylation. These mutant Abs, when conjugated with chelates and large drug complexes at their CH r appended CHOs, showed superior coupling efficiencies with no adverse effects on the resultant immunoreactivities (Qu et al., unpublished observations) .
Unlike the location of potential N-linked glycosylation sites, the compositions and structures of the attached CHOs cannot be predetermined by DNA manipulation. Yet their structural compositions are important in determining the chemistry, efficiency, and extent of conjugation, as well as the types of effector molecules (e.g., chelates, drugs, peptides, etc.) that can be conjugated. To optimize the HCN1-and HCN5-appended CHOs for site-specific conjugation, we attempted to elucidate the profile and sequence of the CHOs at these sites by die method of fluorophore-assisted carbohydrate electrophoresis (FACE). The chemical compositions and structures of these CHOs, and dieir implications, are discussed in this report.
Results
The engineered sites, HCN1 and HCN5, are differentially glycosylated hLL2HCNl and hLL2HCN5 were selected from a battery of hLL2 variants, each of which was engineered with a tripeptide acceptor sequence (Asn-X-Ser/Thr) for N-linked glycosylation in the CH, domain (Table I ). Glycosylation of the HCN1 site in hLL2HCNl is at Asnl62 (NSS), which is located in the middle of the P-strand C. The HCN5 site of hLL2HCN5 lies in the loop between die {3-strands E and F, and glycosylation is at Asnl98 (NGT). When F(ab') 2 fragments of these Abs were analyzed on SDS-PAGE under reducing conditions, their Fd fragments showed reduced mobility when compared with that of hLL2, indicating these sites were glycosylated (data not shown). The apparent molecular size of the Fd fragment of HCN5 appeared to be larger than that of HCN1, suggesting a larger HCN5-appended CHO moiety. The presence of these CH r appended CHOs on hLL2HCNl and hLL2HCN5, albeit their structural and size differences, did not affect their immunoreactivities when compared with that of the parent hLL2, suggesting that glycosylation at the HCN1 and HCN5 sites in the CH, domain would not have adverse effects on the overall structure of the mAb.
To quantitatively evaluate the sizes of these CH^appended oligosaccharides, F(ab') 2 fragments of hLL2, hLL2HCNl, and hLL2HCN5 were prepared and subjected to mass spectrometry analysis (Mass Consortium, San Diego, CA). The mass spectrometry-measured molecular mass of the F(ab')2 fragments of hLL2, hLL2HCNl, and hLL2HCN5 were 99,471, 102,884, and 104,345, respectively (Table I) . Since the Fc portion containing the CH 2 -appended CHO was excluded, the mass difference between the F(ab') 2 fragments of nonglycosylated hLL2 and the glycosylation mutants should represent the mass of the engineered, CH,-appended CHOs. Therefore, the molecular sizes of HCN1-and HCN5-appended CHOs were calculated to be approximately 3400 and 4900 Da, respectively (Table I) . Taking the molecular weight of an average monosaccharide residue to be 240, we estimated that HCN5- appended CHO should contain three to four more monosaccharide residues than that attached to the HCN1 site. It was later confirmed by detailed structural analysis of the engineered CHOs.
The CH r appended CHOs isolated from hLL2HCNl and hLL2HCN5 contain heterogeneous species
The structures of CH,-appended CHOs of hLL2HCNl and hLL2HCN5 were determined using FACE (Starr et al, 1996) , which involves releasing, separating, quantifying, and sequencing of complex oligosaccharides from glycoproteins. relinked oligosaccharides were released from hLL2HCNl or hLL2HCN5 by PNGase F digestion, purified and labeled with ANTS at the free reducing end (see Materials and methods). Since one molecule of ANTS attaches to one molecule of oligosaccharide, the relative amount of different CHO species can, therefore, be accurately determined after being fractionated in high concentration polyacrylamide gel.
Heterogeneous populations of oligosaccharides were released from the F(ab') 2 fragments of hLL2HCNl and hLL2HCN5 ( Figure 1 ). The CH,-appended CHOs isolated from the F(ab') 2 of hLL2HCNl appeared in the FACE gel as multiple bands, of which the two major oligosaccharide species with apparent sizes of 7.3 and 10.2 DP were named as Nl-b and Nl-c, respectively ( Figure 1 , lane B). Similarly, multiple species were found with the oligosaccharides from the HCN5 site and the three major ones were designated as N5-bl (7.3 DP), N5-b2 (7.6 DP), and N5-c (10 DP), respectively ( while Nl-b was the most abundant species, accounting for 55% of all labeled oligosaccharides from the HCN1 site, N5-bl, which comigrated with and was considered equivalent to Nl-b, only accounted for less than 20% of the labeled HCN5 oligosaccharides (Table II) . These two oligosaccharides were later proved to have identical structures by sequencing (see below). Over 60% of the HCN5 oligosaccharides were of the species N5-b2 and N5-c, each of which contained an extra outer branch composed of Sia, Gal(s), and GlcNAc (see below). To examine and compare structural similarities or differences between HCN1-and HCN5-appended oligosaccharides, the major ANTS-oIigosaccharide species, Nl-b, Nl-c, N5-bl, N5-b2, and N5-c, were isolated for sequencing. A minor CHO species, N5-a (6.0 DP, 6.5% of total CHO content), which was only observed in HCN5 profile, was also sequenced. The HCN5-associated CHO species migrating at 13 DP (<10% of total CHO content) was probably structurally related to N5-c, because it comigrated with the NANaseUI-treated N5-c CHO (Table IT) , and should represent the asialylated or desialylated N5-c. Therefore, it was not subjected for further analyses.
Sequence analyses of HCN1-and HCN5-associated oligosaccharides
Most commonly found N-linked CHOs that are extensively processed in vivo are complex-type chains, which contain either two, three or four outer branches extending from the common pentasaccharide core, Manal-3(Manal-6)Man(31-4GlcNAcpi^GlcNAc. The basic outer branch is Gal(31-4GlcNAc (N-acetyllactosamine), onto which other sugar residues may attach, forming various structures (Komfeld and Kornfeld, 1985) . Sialylation (a2-3 or 6 linked) at the Gal residue is one of the most common substitutions. Based on the general structural scheme, oligosaccharides were sequentially digested with exoglycosidases and the digested products were analyzed in FACE gels. Shown in Figure 2 is a typical FACE oligosaccharide sequencing profile for N5-bl. This profile is used here as an example to illustrate the approach and rationale for CHO structural determination. Structures of other oligosaccharides were elucidated with similar approaches and are summarized in Table II .
Most HCN1-and HCN5-associated oligosaccharides are sialylated. As shown in Figure 2 , N5-bl is a 7.3 DP species (lane B). Digestion of N5-bl with NANaseUI caused an upward band shift to 9.2 DP, a change of +1.9 DP units (Figure 2 , compare lanes B and C), which was interpreted as the loss of two charged Sia residues (see Materials and methods). Similar band shifts were observed with Nl-b and N5-a, whereas a change of +3 DP units, corresponding to the loss of three Sia residues, was associated with N5-b2 and N5-c (Table II) . Except for Nl-c, none of these oligosaccharides (Nl-b and all N5 species) were digested by galactosidases (GALasein and GALasea) without prior NANaseUI treatment (data not shown), suggesting that their outer branches were all blocked by terminally or internally attached Sia residues. The apparent size of Nl-c was not changed after NANaseHJ digestion indicating it was not sialylated (Table IT) .
a-Galactosyl epitopes were present in HCN1-and HCN5- •Determined by densitometry. The fluorescent density of all visible bands were quantitated and normalized as 100. '"Calibrated by glucose oligomer ladder. The numbers indicate the positions of completely digested products.
•"Digested with NANaseffl alone. *Digested with GALasem and GALasea plus NANasem "Digested with HEXasem plus NANasem, GALasem, and GALasea. associated oligosaccharides. Digestion of the desialylated N5-bl with GALaselH resulted in a downward band shift of 1.2 DP, due to the removal of one Gal residue (Figure 2 , compare lanes C and D). Subsequent digestion with HEXaselH resulted in the removal of only one GlcNAc residue (data not shown). These results showed that one of the outer branches of N5-bl was Siaa2-3(or 6)Galpl^GlcNAc. When the desialylated N5-bl was digested with GALasein plus GALaseot, the resulting oligosaccharide migrated to about 6.1 DP (Figure 2 , lane E). When the band in lane E was compared with that in land D (Figure 2) , a -1.9 DP band shift, corresponding to the release of two additional Gal residues, was detected. Therefore, N5-bl contained a total of three Gal residues. In separated analyses, digestion with GALasea alone released just one galactose from the desialylated N5-1, indicating that one of the three galactoses was otl-3 linked to the next sugar residue, and subsequent digestion with HEXaseHI did not release any GlcNAc, suggesting that this Gal was not directly linked to GlcNAc (data not shown). Considering all of these results, it was deduced that the other outer branch of N5-bl should be sialylated Galal-3Gaipi-4GlcNAc, also known as the a-galactosyl epitope, which is commonly found in the glycoproteins produced by murine cell lines (Tsuji et al, 1990; Borrebaeck et al., 1993) . Similar analyses were applied to other CHO species and the sequencing profiles showed that they contained either two (Nl-b, Nl-c, and N5-a) or three (N5-b2 and N5-c) outer branches (Table II) . The a-galactosyl epitope was found in all major CHO species: Nl-b, N5-bl, and N5-b2 contained one and N5-c contained two sialylated epitopes, while Nl-c had two asialylated epitopes (Table IT) .
HCNl-and HCN5-associated oligosaccharides are core fucosylated complex-type.
Further digestion of the NANaseHI, GALaseffl, and GALasea treated N5-bl with HEXaseHI resulted in the removal of two GlcNAc residues (Figure 2 , compare lanes E and F). Because each complex-type outer branch extended from the common pentasaccharide core through a GlcNAc residue, the release of two GlcNAc residues by HEXasein confirmed the biantennary structure of N5-bl deduced from the above analyses. The resulting oligosaccharide showed an apparent size of 4.8 DP (Figure 2, lane F) , which corresponded to the size of a fucosylated pentasaccharide core. When other HCNl and HCN5 CHO species were subjected to the same treatment, they all gave rise to similar 4.8 DP products (Table II) . Subsequent treatments of these 4.8 DP products with FUCasel and/or MANasell resulted in identical digestion patterns as in N5-bl (Figure 2, lanes G and H) , suggesting that all HCNl and HCN5 CHO species sequenced contained the same core structure. Digestion of the 4.8 DP product with FUCasel resulted in a -0.6 DP change, indicating the removal of one Fuc residue (Figure 2, compare lanes F and G) . The 4.2 DP product (Figure 2 , lane G) should represent the pentasaccharide core structure (Masada et al., 1996) . Subsequent digestion of the 4.2 DP product with MANasell yielded two bands (Figure 2 , lane H) with apparent sizes of 3.5 and 2.7 DP, corresponding to the loss of one and two Man (mannose) residues, respectively. The 2.7 DP band was confirmed to comigrate with the chitobiose core, Man(31-4GlcNAc(31^MjlcNAc (data not shown). Therefore, all HCNl-and HCN5-CH0 species were confirmed to have the same fucosylated core structure and the heterogeneities of the CHOs arose from different degrees of processing in the outer branches.
HCN5-associated oligosaccharides are structurally favorable for efficient conjugation. Based on the above sequence analyses, the overall structures of HCNl-and HCN5-associated CHOs were elucidated and are summarized in Table  m . While all HCNl-appended oligosaccharides sequenced (Nl-b and Nl-c) were found to be biantennary, over 60% of HCN5-appended oligosaccharides, including species N5-b2 and N5-c, were triantennary structures (Table El) . These results were consistent with our mass spectrometry analyses. Since HCN5-appended oligosaccharides contain more sugar residues than HCNl-appended ones, site-specific conjugation at CH,-appended CHOs with hLLHCN5 should yield a higher substitution ratio, which was confirmed by conjugation studies with DTPA and an anti-cancer agent, doxorubicin (Qu et al., unpublished observations).
Discussion
We have generated two hLL2 derivatives with N-linked oligosaccharides engineered in the CH, domains. These CHOs were primarily designed to be used as specific conjugation sites for radionuclides and drugs. Therefore, their physical properties and structural compositions have become important in determining the optimal chemistry and efficiencies for conjugations. CHOs located at different positions within the same peptide can be differentially processed in vivo. For instance, while the CHOs attached at Asn54 and Asn58 in the heavy chain CDR2 of TKC3.2.2, an anti-dextran mAb, were complex-type, those at Asn60 within the same CDR2 were of high mannose form (Endo et al, 1995) . This positional effect is not well understood. Nevertheless, the identity of the neighboring residues affecting the conformation of the sites, as well as the accessibility of different types of glycosyltransferases to the sequence should be in part responsible for the phenomenon. Both the HCNl and HCN5 sites appeared to be efficiently utilized for glycosylation, all of the CHOs sequenced were of complextype, with the CHOs on HCNl being predominantly biantennary (100%) and that on HCN5 mostly triantennary (60%). The addition of residues forming the outer branch chains in complex-type oligosaccharide synthesis is a relatively late event occurring in the trans Golgi apparatus (Kornfeld and Kornfeld, 1985) . It is likely that the topographical microenvironment at the HCN5 site attached with the nascent CHO precursor, GlcNAcjMa^GlcNAc^, was permissible for the appropriate enzyme, such as N-acetylglucosaminyltransferase IV or V, to add a third GlcNAc to one of the a-Man residues of the core as the third outer branch point (Schachter et al., 1983) ; such spatial environment, however, might be lacking in the case of HCNl.
Since in vivo synthesis of N-linked oligosaccharides is an indirect genetically controlled event involving both co-and posttranslational processing. The presence of differentially processed CHOs, as found in HCNl and HCN5 (Figure 2 , Table HI), should be considered as an inherent characteristic for all glycoproteins. The heterogeneity, however, can vary under different culture conditions (Patel et al, 1992) , or when the proteins are expressed in different cell lines. Although the total number of CHO species released from hLL2HCNl or hLL2HCN5 remained unchanged, variations in their relative abundances, as reflected in the CHO profiling, have been observed with different Ab preparations (data not shown). These microheterogeneities were not detectable using other analytical methods, such as SDS-PAGE and mass spectrometry.
Despite their high degree of heterogeneities, the structure types, and the degree of galactosylation and fucosylation of the 
Nl-c N5-c 'Sugar residues are represented by symbols: triangle, Fuc; diamond, Sia; square, GlcNAc, white circle, Man, grey circle, £-Gal; black circle, a-Gal. The Sia residues whose linkage sites were not determined are indicated with brackets These Sia residues could link to fi-Gal or GlcNAc (see Discussion).
engineered CHOs, are relatively consistent when compared to that of the Fc-associated CHO at Asn297. There are high percentages of incompletely processed CHO species, varying in structure-types (complex-or high mannose-type), amounts of Sia, Gal, and/or GlcNAc residues in the outer branches, core fucosylation, etc., found in the Fc-associated CHOs in human (Harada et al., 1987; Endo et al, 1989) , mouse (Mizuochi et al, 1987) , and from hybridomas (Tandai et al, 1991; Ip et al., 1994) . This might be a result of the restrictive spatial orientation of the Fc-appended CHOs, limiting the accessibility of relevant enzymes to the CHO for complete processing. By contrast, all CHO species isolated from hLL2HCNl and hLL2HCN5 were found to be core-fucosylated complex-type, and all branches, either in biantennary or triantennary structure, were fully elongated, containing Gal and GlcNAc residues. This structural consistency suggests the lack of major steric hindrance preventing necessary enzymes from acting on these sites. This observation is in accordance with our original design that the sites (HCNl and HCN5) should be at exposed positions. Computer modeling studies indicated that, using the biantennary or triantennary structures as the attached CHO at HCNl and HCN5 sites, respectively, the engineered CHOs could clearly be seen exposed at the surface for enzymatic processing, with the CHO at HCNl and HCN5 located in the middle and bottom of the CH, domain, respectively (Qu et al., unpublished observations) . Like all other human or humanized Abs expressed in cell lines of murine origin (Tandai et al., 1991; Ip et al, 1994; ) , HCNl and HCN5-associated CHOs were found to be mousetype (Matsui et al., 1989) , i.e., none of them contained the bisecting GlcNAc structure, which is linked to the a-Man residue of the pentasaccharide core found in CHOs from human IgGs (Tandai et al., 1991) . Of interest is the presence of the so-called a-galactosyl epitope in the HCNl and HCN5-appended CHOs. The a-galactosyl epitope is the product of al-3galactosyltransferase, which is expressed in most mammals except Old World primates and humans (Galili et al., 1988) . Its presence on the cell surface of other mammals has been held responsible for the rapid rejection commonly seen after xenograft transplantation in human (Good et al., 1992; Groth et al, 1996) . It is possible that hLL2HCNl and hLL2HCN5 carrying such an epitope will elicit immune responses in human similar to that observed in xenograft rejection. This problem, however, can be circumvented by producing the HCNl and HCN5 mutants in human cell lines, or in cell lines lacking al-3galactosyltransferase.
As much as 60 and 90% of CHO species from HCNl and HCN5, respectively, were sialylated (Table II) . Of those that were sialylated, Sia residues could be identified in all the outer branches of either biantennary or triantennary structures. This is in contrast with the study by Endo et al., who found a higher percent molar ratio of sialylated CHO species (23-31%) in V region-appended, complex-type oligosaccharides, as compared to that found in the Fc (12-15%) ; none of the sialylated CHOs analyzed contained two or more Sia residues (Endo et al., 1995) . The exact position where the Sia residue was attached to the a-galactosyl epitope in HCN1-and HCN5-CHOs, however, was not determined. It is known that sialylation of Nlinked CHOs in vivo is mediated by sialytransferases with restricted substrate specificities, and no a-galatoside sialyltransferase has been reported (Kornfeld and Komfeld, 1985) . Yet possibilities still exist that sialylation at the P-Gal or the GlcNAc residues can be accomplished via the actions of (3-galactoside ot2,6 sialyltransferase (van den Eijnden et al., 1980; Beyer et al., 1981) or N-acetylglucosaminide a2,6 sialyltransferase (Mizuochi et al., 1979; Paulson et al., 1984) , respectively. Further analyses with NANases of different specificities should be able to identify the linkages and sites of the Sia residues in the a-galactosidyl epitope.
Knowing the size, composition and structure of the engineered CHO is crucial for us to develop efficient methods and protocols for site-specific conjugation. For example, the number of potential active sites can be deduced from the known structure. Chemical conjugation methods needed to achieve the theoretical maximum loading capacity can then be devised. Alternatively, specific sugar residues can be targeted for conjugation. For example, terminal galactose residues have been chemically activated by perioxidation (Morell and Ashwell, 1972) , or enzymatically activated by galactose oxidase (GAO) for peptide conjugation (Brumeanu et al., 1995) .
In summary, we have determined, by using FACE, the compositions and sequences of oligosaccharides engineered into the CHj-domain of hLL2. For site-specific attachment of chelates and drugs, the CHOs in the CH[-domain of IgG are structurally superior compare to Fc-or V region-appended CHOs.
Materials and methods

Antibodies and F(ab') 2 fragments
Construction, expression, production and purification of the N-linked glycosylation mutant mAbs, hLL2HCNl and hLL2HCN5, have been described elsewhere (Qu et al, unpublished observations). To prepare F(ab') 2 fragments, purified mAbs at a concentration of 2 mg/ml in 0.05 M sodium citrate (pH 3.4) with 10% glycerol was digested with 10 |xg/ml of pepsin (Worthington, Freehold, NJ) at 37°C. The extent of digestion was monitored by HPLC. At the completion of digestion (approximately 10 min), the reaction was terminated by the addition of 1/10 volume of 1 M Tris (pH 8.0) to the reaction mixture. The reaction mixture was passed through a protein A column and F(ab')2 fragments were then purified from Sepharose S column (Pharmacia, Piscataway, NJ).
N-linked oligosaccharide profiling and sequencing
FACE was used for profiling and sequencing of N-linked oligosaccharides. The N-linked oligosaccharides were released from 200 u,g of denatured (0.2% SDS, 100 mM B-mecaptoethonal, boiled for 3 min) ¥(&% fragments by reacting with 2 units of peptide N-glycosidase F (PNGase F, Boehringer Mannbein, Indianapolis, IN) in 0.1 M potassium phosphate buffer (pH 7.0) with 2% NP-40 at 37°C for 16 h. The released oligosaccharides were then labeled with the fluorophore 8-ammonaphthalene-l,3,6-trisulfonic acid (ANTS) using Nlinked oligosaccharide profiling kit according to the manufacturer's specifications (Bio-Rad, Hercule, CA). The apparent size of each ANTSoligosaccharide in polyacrylamide gel was estimated from glucose oligomer ladder standards and expressed as degree of polymerization (DP). Individual ANTS-labeled oligosaccharide species was isolated from polyacrylamide gels and further sequenced by sequential digestion with combinations of recombinant exoglycosidases (obtained from Glyko, Novato, CA), including: Nacetylneuraminidase III (NANaseHI, cleaves a2-3,6,8 linked N-acerylneuraminic acids), B-galactosidase ru (GALasem, specific for 81-4 linked galactose), galactosidase a (GALasea, a 1-3 linked galactose-specific), P-Nacetylhexosaminidase III (HEXaseHI, hydrolyzes B1,-2,3,4,6 linked Nacetylglucosamine), a-mannosidase II (MANaseH, cleaves a 1-2,3,6 linked mannose), and a-fucosidase I (FUCasel, a 1-6 linked fucose-specific), using conditions suggested by the suppliers (Bio-Rad and Glyko). The ANTSoligosacchande band shifts resulting from exoglycosidase digestions were compared to the reference data provided in the protocol menu (Bio-Rad). Interpretation of tne results was based on the following guidelines: removal of a sialic acid (Sia) residue causes an upward shift of 1 DP (+1), and removal of one residue of galactose (Gal), N-acetylglucosamine (GlcNAc), mannose (Man) or fucose (Fuc) results in a downshift of (-)l, (-)0.75, (-)0.6 and (-)0.6 DP unit, respectively.
